SCHEMBL5171102

SCHEMBL5171102

CS(=O)(=O)c1c(C(N)=O)cccc1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCAT2 O15382 1/20 0.61
▸ KEAP1 Q14145 1/20 0.46
▸ NFE2L2 Q16236 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ HNF4A P41235 1/20 0.45
▸ IKBKB O14920 6/20 0.44
▸ CHUK O15111 4/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ BRD4 O60885 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ FGFR1 P11362 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ FGFR2 P21802 1/20 0.41
▸ FGFR4 P22455 1/20 0.41
▸ FGFR3 P22607 1/20 0.41
▸ CRHBP P24387 1/20 0.41
▸ CRHR2 Q13324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2943710 0.88 MKNK1 (0.50) BCAT2KEAP1NFE2L2PTGS2IKBKB
SCHEMBL30903647 0.85 BCAT2 (0.62) BCAT2KEAP1NFE2L2HNF4AIKBKB
SCHEMBL17593027 0.85 BCAT2 (0.62) BCAT2KEAP1NFE2L2HNF4AIKBKB
Dimethyl Sulfone SCHEMBL28171504 0.83 BCAT2 (0.81) BCAT2KEAP1NFE2L2PTGS2HNF4A
SCHEMBL30309077 0.83 BCAT2 (0.59) BCAT2KEAP1NFE2L2HNF4AIKBKB
SCHEMBL5136386 0.81 BCAT2 (0.79) BCAT2KEAP1NFE2L2PTGS2HNF4A
SCHEMBL11615948 0.81 SLC6A3 (0.51) PTGS2MEN1KMT2AFGFR1SRC
SCHEMBL15562585 0.80 BCAT2 (0.51) BCAT2KEAP1NFE2L2HNF4AIKBKB
SCHEMBL5189493 0.79 BCAT2 (0.54) BCAT2KEAP1NFE2L2HNF4AIKBKB
SCHEMBL29427545 0.77 BCAT2 (1.00) BCAT2KEAP1NFE2L2HNF4AIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970216-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2016-01-20 — — EP disclosed
WO-2014151616-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS NOVARTIS AG (CH) 2014-09-25 — — WO disclosed
EP-1773774-A2 HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merck & Co., Inc. (US) 2007-04-18 — — EP disclosed
EP-1773792-A1 INDANONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merck & Co., Inc. (US) 2007-04-18 — — EP disclosed
WO-2006014918-A2 HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK & CO., INC. (US) 2006-02-09 — — WO disclosed
WO-2006015158-A1 INDANONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK & CO., INC. (US) 2006-02-09 — — WO disclosed
Send feedback